TC
CSTL icon

TownSquare Capital’s Castle Biosciences CSTL Stock Holding History

TownSquare Capital’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,772
Closed -$476K – 804
2025
Q1 		$476K Buy
23,772
+1,584
+7% +$39.2K 0.01% 1149
2024
Q4 		$591K Sell
22,188
-1,082
-5% -$33K 0.01% 951
2024
Q3 		$664K Buy
23,270
+4,688
+25% +$119K 0.01% 862
2024
Q2 		$405K Sell
18,582
-770
-4% -$17.2K 0.01% 957
2024
Q1 		$429K Sell
19,352
-3,389
-15% -$73.7K 0.01% 893
2023
Q4 		$491K Sell
22,741
-3,242
-12% -$57.1K 0.01% 786
2023
Q3 		$439K Sell
25,983
-11,711
-31% -$205K 0.01% 798
2023
Q2 		$517K Buy
37,694
+24,798
+192% +$502K 0.01% 757
2023
Q1 		$293K Buy
12,896
+736
+6% +$18K 0.01% 837
2022
Q4 		$286K Buy
+12,160
New +$282K 0.01% 805
2021
Q4 		– Sell
-3,702
Closed -$246K – 723
2021
Q3 		$246K Buy
3,702
+16
+0.4% +$1.13K 0.01% 617
2021
Q2 		$265K Buy
+3,686
New +$243K 0.01% 518

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

TownSquare Capital's CSTL Position: Q2 2025 in Review

TownSquare Capital sold out of Castle Biosciences (CSTL) in Q2 2025, closing a stake of 23,772 shares — an estimated $476K sold.

TownSquare Capital first reported a position in CSTL in Q2 2021 and held it in 12 quarters. The position peaked at $664K in Q3 2024. 152 funds tracked by Wall St. Rank hold CSTL as of Q2 2025.

  • TownSquare Capital reported no remaining Castle Biosciences position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 23,772 Castle Biosciences shares in Q2 2025, an estimated $476K.
  • TownSquare Capital first reported a position in Castle Biosciences in Q2 2021 and held it in 12 quarters.
  • TownSquare Capital's Castle Biosciences position peaked at $664K in Q3 2024.
  • 152 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.